Atlas Trials

Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective Study

Clinical trial NCT07657299 · COMPLETED

Trial details

NCT number
NCT07657299
Sponsor
Ain Shams University
Status
COMPLETED
Study type
OBSERVATIONAL
Bladder CancerBladder Cancer Recurrence
Start date
2022-04-01
Primary completion
2024-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.